Results
1 -
10 of
18
(Click
here to explore results)
- Advances in Nucleic Acid Therapeutics, CHAPTER 4 Antisense Technology: Liver Targeting and Beyond for Drug Discovery. Richard S. Geary, Brenda F. Baker, Brett P. Monia
, 2019
, Pages 62-79
- Advances in Nucleic Acid Therapeutics, CHAPTER 3 The Medicinal Chemistry of RNase H-activating Antisense Oligonucleotides. Punit P. Seth, Eric E. Swayze
, 2019
, Pages 32-61
- Orphan Drugs and Rare Diseases, Chapter 4 Treating Rare Diseases: Business Model for Orphan Drug Development. Cory Williams
, 2014
, Pages 83-111
- Cardiovascular and Metabolic Disease: Scientific Discoveries and New Therapies, Chapter 10 New Drug Design and Therapeutic Development for Heart Failure. Elnaz Menhaji-Klotz, Thomas V. Magee
, 2015
, Pages 186-218
- Advances in Nucleic Acid Therapeutics, CHAPTER 20 Preclinical and Clinical Drug-metabolism, Pharmacokinetics and Safety of Therapeutic Oligonucleotides. Patrik Andersson, Cathaline den Besten
, 2019
, Pages 474-531
- Advances in Nucleic Acid Therapeutics, Foreword
, 2019
, Pages P007-P008
- Nuclear Magnetic Resonance: Volume 40, NMR in living systems. M.J.W. Prior
, 2011
, Volume 40
, Pages 472-533
- New Applications of NMR in Drug Discovery and Development, CHAPTER 13 In Vivo MRI/S for the Safety Evaluation of Pharmaceuticals. Paul D. Hockings, Helen Powell
, 2013
, Pages 361-375
- Advances in Nucleic Acid Therapeutics, CHAPTER 9 Oligonucleotide Targeting of Long Non-coding RNAs. I. Blokhin, O. Khorkova, J. Hsiao, C. Wahlestedt
, 2019
, Pages 181-205
- Cardiovascular and Metabolic Disease: Scientific Discoveries and New Therapies, Subject Index
, 2015
, Pages 366-376